{"id":290257,"date":"2025-08-02T01:00:21","date_gmt":"2025-08-02T01:00:21","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/290257\/"},"modified":"2025-08-02T01:00:21","modified_gmt":"2025-08-02T01:00:21","slug":"une-pilule-contraceptive-pour-homme-en-cours-de-developpement-une-commercialisation-prevue-en-2029","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/290257\/","title":{"rendered":"Une pilule contraceptive pour homme en cours de d\u00e9veloppement\u00a0: une commercialisation pr\u00e9vue en 2029"},"content":{"rendered":"<p>Le laboratoire am\u00e9ricain YourChoice Therapeutics annonce des r\u00e9sultats prometteurs pour YCT\u2011529, une pilule contraceptive masculine non hormonale.<\/p>\n<p>Les premiers essais cliniques r\u00e9alis\u00e9s sur 16 volontaires n\u2019ont r\u00e9v\u00e9l\u00e9 aucun effet secondaire majeur, ni baisse de libido, ni perturbation hormonale.<\/p>\n<p>Le traitement agit en bloquant une prot\u00e9ine cl\u00e9 dans la production de spermatozo\u00efdes, tout en pr\u00e9servant la testost\u00e9rone. La fertilit\u00e9 serait r\u00e9versible entre 3 \u00e0 6 mois apr\u00e8s l\u2019arr\u00eat. Une seconde phase d\u2019essais, sur plusieurs semaines, est pr\u00e9vue prochainement.<\/p>\n<p>La commercialisation est envisag\u00e9e pour 2029, une avanc\u00e9e majeure dans le partage de la charge contraceptive entre hommes et femmes.<\/p>\n","protected":false},"excerpt":{"rendered":"Le laboratoire am\u00e9ricain YourChoice Therapeutics annonce des r\u00e9sultats prometteurs pour YCT\u2011529, une pilule contraceptive masculine non hormonale. Les&hellip;\n","protected":false},"author":2,"featured_media":290258,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[47,1011,27,72,6335,1922,6336,7224,71,104],"class_list":{"0":"post-290257","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-actualite","9":"tag-fr","10":"tag-france","11":"tag-health","12":"tag-home-page","13":"tag-info","14":"tag-la-reunion","15":"tag-newsletter-soir","16":"tag-sante","17":"tag-societe"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114956469856753832","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/290257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=290257"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/290257\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/290258"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=290257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=290257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=290257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}